{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T04:06:58Z","timestamp":1749701218289,"version":"3.41.0"},"reference-count":45,"publisher":"Begell House","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Environ Pathol Toxicol Oncol"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>Bladder cancer (BCa) is approximately the fourth most prevalent diagnosed cancer in men and is three times less common in women. Therefore, identifying biomarkers, developing more effective therapeutic strategies, and understanding the mechanisms underlying BCa tumor growth and progression are urgently required to improve survival rates. Therefore, we aim to investigate the expression of PTEN\/Akt in tissue samples of both non-muscle invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) patients (&lt;i&gt;n&lt;\/i&gt; &amp;#61; 70) and human BCa cell lines T24 and 5637, along with the potent role of ellagic acid (EA) in the modulation of the PTEN\/Akt pathway and the resulting therapeutic potential. Results showed low-intensity nuclear or cytoplasmic PTEN staining or loss of PTEN expression in tumor cells and overexpression of p-Akt (Ser-473) with high intensity in the nucleus or cytoplasm. EA treatment of T24 and 5637 cells reduced cell viability, inflammation (NF-&amp;kappa;B, COX-2), invasion (MMP-9), induced the caspase (cas-3 and cas-9) cascade signaling pathway, and induced cell apoptosis along with the suppression of the PI3K\/PTEN\/Akt signaling pathway after 48h in a dose-dependent manner. Thus, these data suggested that the EA showed a strong potential anti-cancer effect in T24 and 5637 cells. In conclusion, the expression of PTEN\/p-Akt and the inverse relation indicated an alteration of the PTEN\/Akt pathway, and such cases could benefit from treatment with EA in BCa.\n<\/p>","DOI":"10.1615\/jenvironpatholtoxicoloncol.2024053383","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T15:06:07Z","timestamp":1730214367000},"page":"57-69","source":"Crossref","is-referenced-by-count":0,"title":["Anti-Cancer Role of Ellagic Acid by Modulating the Altered PI3K\/PTEN\/Akt Pathway in Bladder Cancer"],"prefix":"10.1615","volume":"44","author":[{"given":"Satya","family":"Sahay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepika","family":"Trehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranbala","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawan","family":"Vasudeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niraj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usha","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"613","reference":[{"doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics 2019. CA Cancer J Clin. 2019;69:7-34.","key":"2","DOI":"10.3322\/caac.21551"},{"doi-asserted-by":"crossref","unstructured":"Ro JY, Staerkel GA, Ayala AG. Cytologic and histologic features of superficial bladder cancer. Urol Clin North Am. 1992;19:435-53.","key":"3","DOI":"10.1016\/S0094-0143(21)00412-2"},{"unstructured":"Youyan G, Nianzeng X, Jianzhong S. The epidemiological status of urinary malignancies in China. Can Res. 2019;22:67-72.","key":"4"},{"doi-asserted-by":"crossref","unstructured":"James ND, Hussain SA, Hall E, Jenkins P, Tremlett J, Rawlings C, Crundwell M, Sizer B, Sreenivasan T, Hendron C, Lewis R, Waters R, Huddart RA. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med. 2012;366:1477-88.","key":"5","DOI":"10.1056\/NEJMoa1106106"},{"doi-asserted-by":"crossref","unstructured":"Herlevsen M, Oxford G, Ptak C, Shabanowitz J, Hunt DF, Conaway M. A novel model to identify interaction partners of the PTEN tumor suppressor gene in human bladder cancer. Biochem Biophys Res Commun. 2007;352:549-55.","key":"6","DOI":"10.1016\/j.bbrc.2006.11.067"},{"doi-asserted-by":"crossref","unstructured":"Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JFM. The PTEN\/PI3K\/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets. 2008;8:187-98.","key":"7","DOI":"10.2174\/156800908784293659"},{"doi-asserted-by":"crossref","unstructured":"Jiang BH, Liu LZ. PI3K\/PTEN Signaling in angiogenesis and tumorigenesis. Adv Cancer Res. 2009;102:19-65.","key":"8","DOI":"10.1016\/S0065-230X(09)02002-8"},{"doi-asserted-by":"crossref","unstructured":"Sfakianos JP, Gellert LL, Maschino A, Gotto GT, Kim PH, Al-Ahmadie H, Bochner BH. The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder. Urol Oncol. 2014;32:657-62.","key":"9","DOI":"10.1016\/j.urolonc.2014.02.003"},{"doi-asserted-by":"crossref","unstructured":"Cordes I, Kluth M, Zygis D, Rink M, Chun F, Eichelberg C, Dahlem R, Fisch M, Hoppner W, Wagner W, Doh O, Terracciano L, Simon R, Wilczak W, Sauter G, Minner S. PTEN deletions are related to disease progression and unfavourable prognosis in early bladder cancer. Histopathology. 2013;63:670-7.","key":"10","DOI":"10.1111\/his.12209"},{"doi-asserted-by":"crossref","unstructured":"Lui VWY, Hedberg ML, Li H, Vangara BS, Pendleton K, Zeng Y, Lu Y, Zhang Q. Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discov. 2013;3:761-9.","key":"11","DOI":"10.1158\/2159-8290.CD-13-0103"},{"doi-asserted-by":"crossref","unstructured":"Khezri MR, Jafari R, Yousefi K, Zolbanin NM. The PI3K\/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions. Exp Mol Pathol. 2022;127:104787.","key":"12","DOI":"10.1016\/j.yexmp.2022.104787"},{"doi-asserted-by":"crossref","unstructured":"Song M, Wang X, Luo Y, Liu Z, Tan W, Ye P, Fu Z, Lu F. Xiang W, Tang L, Yao L. Cantharidin suppresses gastric cancer cell migration\/invasion by inhibiting the PI3K\/Akt signaling pathway via CCAT1. Chem Biol Interact. 2020;317:108939.","key":"13","DOI":"10.1016\/j.cbi.2020.108939"},{"doi-asserted-by":"crossref","unstructured":"Hoxhaj G, Manning BD. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer. 2020;20:74-88.","key":"14","DOI":"10.1038\/s41568-019-0216-7"},{"doi-asserted-by":"crossref","unstructured":"Calderaro J, Rebouissou S, de Koning L, Masmoudi A, Herault A, Dubois T, Maille P. PI3K\/AKT pathway activation in bladder carcinogenesis. Int J Cancer. 2014;134:1776-84.","key":"15","DOI":"10.1002\/ijc.28518"},{"doi-asserted-by":"crossref","unstructured":"Xu, T, Rao T, Yu WM, Ning JZ, Yu X, Zhu SM, Yang K, Bai T, Cheng T. Upregulation of NFKBIZ affects bladder cancer progression via the PTEN\/PI3K\/Akt signaling pathway. Int J Mol Med. 2021;47:109.","key":"16","DOI":"10.3892\/ijmm.2021.4942"},{"doi-asserted-by":"crossref","unstructured":"Zhang Z, Xu H, Ji J, Shi X, Lyu J, Zhu Y, Yu H, Wang F. Heterogeneity of PTEN and PPAR \u00ce\u00b3 in cancer and their prognostic application to bladder cancer. Exp Ther Med. 2019;18:3177-83.","key":"17","DOI":"10.3892\/etm.2019.7879"},{"doi-asserted-by":"crossref","unstructured":"Khan K, Quispe C, Javed Z, Iqbal MJ, Sadia H, Raza S, Irshad A, Salehi B, Reiner Z, Sharif Rad J. Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K\/Akt\/mTOR pathway: Go four better to treat bladder cancer. Cancer Cell Int. 2020;20:560.","key":"18","DOI":"10.1186\/s12935-020-01660-7"},{"doi-asserted-by":"crossref","unstructured":"BenSaad LA, Kim KH, Quah CC, Kim WR, Shahimi M. Anti-inflammatory potential of ellagic acid, gallic acid and punicalagin A&B isolated from Punica granatum. BMC Complement Altern Med. 2017;17(1):47.","key":"19","DOI":"10.1186\/s12906-017-1555-0"},{"doi-asserted-by":"crossref","unstructured":"Wang L, Li W, Lin M, Garcia M, Mulholland D, Lilly M, Martins-Green M. Luteolin, ellagic acid and punicic acid are natural products that inhibit prostate cancer metastasis. Carcinogenesis. 2014;35:2321-30.","key":"20","DOI":"10.1093\/carcin\/bgu145"},{"doi-asserted-by":"crossref","unstructured":"Ceci C, Lacal PM, Tentoi L, Martino MGD, Miano R, Graziani G. Experimental evidence of the antitumor, antimetastatic and antiangiogenic activity of ellagic acid. Nutrients. 2018;10:1756.","key":"21","DOI":"10.3390\/nu10111756"},{"doi-asserted-by":"crossref","unstructured":"Eskandari E, Heidarian E, Amini SA, Chaleshtori JS. Evaluating the effects of ellagic acid on pSTAT3, pAKT, and pERK1\/2 signaling pathways in prostate cancer PC3 cells. J Cancer Res Ther. 2017;12:1266-71.","key":"22","DOI":"10.4103\/0973-1482.165873"},{"doi-asserted-by":"crossref","unstructured":"Cheng H, Lu C, Tang R, Pan Y, Bao S, Qiu Y, Xie M. Ellagic acid inhibits the proliferation of human pancreatic carcinoma PANC-1 cells in vitro and in vivo. Oncotarget. 2017;8:12301-10.","key":"23","DOI":"10.18632\/oncotarget.14811"},{"doi-asserted-by":"crossref","unstructured":"Abdallah HMI, El Awdan SA, Abdel-Rahman RF, Farrag ARH, Allam RM. 1,8 Cineole and ellagic acid inhibit hepatocarcinogenesis via upregulation of MiR-122 and suppression of TGF-B1, FSCN1, Vimentin, VEGF, and MMP-9. PLoS One. 2022;17:e0258998.","key":"24","DOI":"10.1371\/journal.pone.0258998"},{"doi-asserted-by":"crossref","unstructured":"Wang Y, Ren F, Li B, Song Z, Chen P, Ouyang L. Ellagic acid exerts antitumor effects via the PI3K signaling pathway in endometrial cancer. J Cancer. 2019;10:3303-14.","key":"25","DOI":"10.7150\/jca.29738"},{"doi-asserted-by":"crossref","unstructured":"Ceci C, Tentori T, Atzori MG, Lacal PM, Bonanno E, Scimeca M, Cicconi R. Ellagic acid inhibits bladder cancer invasiveness and in vivo tumor growth. Nutrients. 2016;8:744-64.","key":"26","DOI":"10.3390\/nu8110744"},{"doi-asserted-by":"crossref","unstructured":"Yousuf M, Shamsi A, Khan P, Shahbaaz M, AlAjmi MF, Hussain A, Islam GMA, Rizwanul Haque QM, Hassan MI. Ellagic acid controls cell proliferation and induces apoptosis in breast cancer cells via inhibition of cyclin-dependent kinase 6. Int J Mol Sci. 2020;21:3526.","key":"27","DOI":"10.3390\/ijms21103526"},{"doi-asserted-by":"crossref","unstructured":"Marcos-Gragera R, Mallone S, Kiemeney LA. Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5. Eur J Cancer. 2015;51:2217-30.","key":"28","DOI":"10.1016\/j.ejca.2015.07.028"},{"doi-asserted-by":"crossref","unstructured":"Schulz GB, Stief CG, Schlenker B. Follow-up surveillance of muscle-invasive urinary bladder cancer after curative treatment. Urologe A. 2019;58(9):1093-106.","key":"29","DOI":"10.1007\/s00120-019-1012-4"},{"doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7-30.","key":"30","DOI":"10.3322\/caac.21387"},{"unstructured":"Rozanec JJ, Secin FP. Epidemiology, etilogy and prevention of bladder cancer. Arch Esp Urol. 2020;73:872-8.","key":"31"},{"doi-asserted-by":"crossref","unstructured":"Peng Y, Wang Y, Zhou C, Mei W, Zeng C. PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: Are we making headway? Front Oncol. 2022;24:819128.","key":"32","DOI":"10.3389\/fonc.2022.819128"},{"doi-asserted-by":"crossref","unstructured":"Zhu K, Wu Y, He P, Fan Y, Zhong X, Zheng H, Luo T. PI3K\/AKT\/mTOR-targeted therapy for breast cancer. Cells. 2022;11:2508.","key":"33","DOI":"10.3390\/cells11162508"},{"doi-asserted-by":"crossref","unstructured":"Sahay S, Tiwari P, Pandey M, Gupta KP. PI3K\/Akt pathway and miR-21 are involved in N-Ethyl-N-Nitrosourea-Induced F1 mouse lung tumorigenesis: Effect of inositol hexaphosphate. J Environ Pathol Toxicol Oncol. 2019;38(1):69-81.","key":"34","DOI":"10.1615\/JEnvironPatholToxicolOncol.2018026684"},{"doi-asserted-by":"crossref","unstructured":"Tiwari P, Sahay S, Pandey M, Qadri SYH, Gupta KP. Preventive effects of butyric acid, nicotinamide, calcium glucarate alone or in combination during the 7, 12-dimethylbenz (a) anthracene induced mouse skin tumorigenesis via modulation of K-Ras-PI3K\/AKTpathway and associated micro RNAs. Biochimie. 2016;121:112e122.","key":"35","DOI":"10.1016\/j.biochi.2015.11.027"},{"doi-asserted-by":"crossref","unstructured":"Liu Q, Liang X, Niu C, Wang X. Ellagic acid promotes A549 cell apoptosis via regulating the phosphoinositide 3 kinase\/protein kinase B pathway. Exp Ther Med. 2018;16:347-52.","key":"36","DOI":"10.3892\/etm.2018.6193"},{"doi-asserted-by":"crossref","unstructured":"Lian-Wei L, Chao N, Song-Yu T, Jien C, Rong M, Ying G, Ge L. Ellagic acid induces hela cell apoptosis via regulating signal transducer and activator of transcription 3 signaling. Exp Ther Med. 2018;16:29-36.","key":"37","DOI":"10.3892\/etm.2018.6182"},{"doi-asserted-by":"crossref","unstructured":"Saeed ZM, Khattab MI, Khorshid NE, Salem AE. Ellagic acid and cilostazol ameliorate amikacin-induced nephrotoxicity in rats by downregulating oxidative stress, inflammation, and apoptosis, PLoS One. 2022;17:e0271591.","key":"38","DOI":"10.1371\/journal.pone.0271591"},{"doi-asserted-by":"crossref","unstructured":"Bhattacharjee VH, Chakraborty M, Habbu PV, Ray AH. Ellagic acid restored lead-induced nephrotoxicity by anti-inflammatory, anti-apoptotic and free radical scavenging activities. Heliyon. 2021;7:e05921.","key":"39","DOI":"10.1016\/j.heliyon.2021.e05921"},{"unstructured":"Zaazaa AM, Lokman MS, Shalby AB, Ahmed HH, El-Toumy SA. Ellagic acid holds promise against hepatocellular carcinoma in an experimental model: Mechanisms of action. Asian Pac J Cancer Prev. 2018;19:387-93.","key":"40"},{"doi-asserted-by":"crossref","unstructured":"Yousuf M, Shamsi A, Khan P, Shahbaaz M, AlAjmi M.F, Hussain A, Hassan GM, Islam A, Rizwanul Haque QM, Hassan MI. Ellagic acid controls cell proliferation and induces apoptosis in breast cancer cells via inhibition of cyclin-dependent kinase 6. Int J Mol Sci. 2020;21:3526.","key":"41","DOI":"10.3390\/ijms21103526"},{"doi-asserted-by":"crossref","unstructured":"Ni X, Shang FS, Wang TF, Wu DJ, Chen DG, Zhuang B. Ellagic acid induces apoptosis and autophagy in colon cancer through the AMPK\/mTOR pathway. Tissue Cell. 2023;81:102032.","key":"42","DOI":"10.1016\/j.tice.2023.102032"},{"doi-asserted-by":"crossref","unstructured":"Iflazoglu MS, Seven I, Arkali G, Birben N, Sur AA, Aksakal M, Tatli SP. Ellagic acid plays an important role in enhancing productive performance and alleviating oxidative stress, apoptosis in laying quail exposed to lead toxicity. Ecotoxicol Environ Saf. 2021;208:111608.","key":"43","DOI":"10.1016\/j.ecoenv.2020.111608"},{"doi-asserted-by":"crossref","unstructured":"Malik A, Afaq S, Shahid M, Akhtar K, Assiri A. Influence of ellagic acid on the prostrate cancer cell proliferation: a caspase-dependent pathway. Asian Pac J Trop Med. 2011;4:550-5.","key":"44","DOI":"10.1016\/S1995-7645(11)60144-2"},{"doi-asserted-by":"crossref","unstructured":"Kim JY, Choi YJ, Kim HJ. Determining the effect of ellagic acid on the proliferation and migration of pancreatic cancer cell lines. Transl Cancer Res. 2021;10:424-33.","key":"45","DOI":"10.21037\/tcr-20-2446"},{"doi-asserted-by":"crossref","unstructured":"Santos BL, Oliveira M.N, Coelho PL, Pitanga BP, Da Silva AB, Adelita T, Silva VDA, de FD Costa M, El-Bacha RS, Tardy M, Chneiweiss H. Flavonoids suppress human glioblastoma cell growth by inhibiting cell metabolism, migration, and by regulating extracellular matrix proteins and metalloproteinases expression. Chem Biol Interact. 2015;242:123-38.","key":"46","DOI":"10.1016\/j.cbi.2015.07.014"}],"container-title":["Journal of Environmental Pathology, Toxicology and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/5e0728b7452eda52\/JEP(T)-53383.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T06:54:55Z","timestamp":1749624895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/0ff459a57a4c08d0,0b717b2d411c7d59,5e0728b7452eda52.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/jenvironpatholtoxicoloncol.2024053383","relation":{},"ISSN":["0731-8898"],"issn-type":[{"type":"print","value":"0731-8898"}],"subject":[],"published":{"date-parts":[[2025]]}}}